Author:
Nedvídková J.,Schreiber V.,Stárka L.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference26 articles.
1. Kawai S., Nieman L.K., Brandon D.D., Udelsman R., Loriaux D.L., Chrousos G.P. Pharmacokinetic properties of the antiglucocortiocoid and antiprogesterone steroid RU 486 in man. J. Pharmacol. Exp. Ther. 241: 401, 1987.
2. Jellinck P.H., Newcombe A.M., Lyttle C.R. Antiandrogenic property of RU 486: enhancement of estrogen-induced uterine peroxidase activity in the rat. J. Steroid biochem. Mol. Biol. 45: 303, 1993.
3. Moguilewsky M., Philibert D. Biochemical profile of RU 486. In: E.E. Baulieu, S.J. Segal (Ed.), The Antiprogestin Steroid RU 486 and Human Fertility Control. Plenum Publ. Corp., p. 87.
4. Wolf J.P., Hsiu J.G., Anderson T.L., Ulman A., Baulieu E.E., Hodgen G.D. Noncompetitive antiestrogenic effect of RU 486 in blocking the estrogen-stimulated luteinizing hormone surge and the proliferative action of estradiol on endometrium in castrate monkeys. Fert. Steril. 52: 1055, 1989.
5. Slayden O.D., Brenner R.M. RU 486 action after estrogen priming in the endometrium and oviducts of rhesus monkeys (Macaca mulatta). J. Clin. Endocrinol. Metab. 78: 440, 1994.